je.st
news
sparkV10 Chosen to Facilitate the Hit Optimization Process in ProMining Therapeutics
2013-01-09 06:00:00| Industrial Newsroom - All News for Today
Welwyn Garden City, UK - Cresset Group, innovative provider of chemistry software and services, announces that ProMining Therapeutics Ltd has chosen to license sparkV10 for assistance in its hit-to-lead optimization efforts. sparkV10 is Cresset's desktop bioisostere software tool which is used by medicinal and computational chemists for drug design. "sparkV10 is an exciting and powerful way of generating novel and diverse structures. We are delighted that ProMining, an early-stage ...This story is related to the following:ServicesScientific Software | Medical & Health Care Software | Desktop Publishing Software | Chemistry Analyzers
Tags: process
hit
chosen
facilitate
Category:Industrial Goods and Services